The prevalence of complex multimorbidity in Australia
The prevalence of complex multimorbidity in Australia
复制标题
DOI：
10.1111/1753-6405.12509
复制
发表时间：
2016-06-01
影响因子：
3.5
通讯作者：
Britt, Helena
中科院分区：
文献类型：
--
作者：
Harrison, Christopher;Henderson, Joan;Britt, Helena
目的：通过一项具有全国代表性的前瞻性研究，评估澳大利亚人群中多发病和复杂多发病的患病率，并确定受影响的慢性病和身体系统最常见的模式。方法：在290名全科医生的访谈中，随机抽取8707名患者进行国家代表性海滩计划的子研究。为每个患者记录所有诊断的慢性病。结果：我们估计：47.4%的全科医生患者和三分之一(32.6%)的患者患有多病；27.4%的全科医生患者和17.0%的澳大利亚人患有复杂的多病。三种疾病最常见的组合模式是高血压+高脂血症+骨关节炎(5.5%的患者和3.3%的人群)。受影响最普遍的三个身体系统的组合是循环+肌肉骨骼+内分泌/营养/代谢系统(11.1%的患者和7.0%的人口)。结论和意义：相当大比例的澳大利亚人不仅有多病，而且有复杂的多病。为了应对复杂的多发病带来的挑战，我们医疗保健系统的单一疾病重点需要重新评估。
Objective: To measure prevalence of multimorbidity and complex multimorbidity in the Australian population from a nationally representative prospective study and to identify the most prevalent patterns of chronic conditions and body systems affected.Methods: A sub-study of the nationally representative BEACH program, using a random sample of 8,707 patients at encounters with 290 general practitioners. All diagnosed chronic conditions were recorded for each patient. Multimorbidity was defined as co-occurrence of 2+ chronic conditions, while complex multimorbidity was defined as 3+ body systems each affected by at least one chronic condition.Results: We estimated: 47.4% of patients at GP encounters and one-third (32.6%) of the population had multimorbidity; and 27.4% of patients at GP encounters and 17.0% of the Australian population had complex multimorbidity. The most prevalent combination pattern of three conditions was hypertension+hyperlipidaemia+osteoarthritis (5.5% of patient at encounters and 3.3% of the population). Most prevalent combination of three body systems affected was circulatory+musculoskeletal+endocrine / nutritional/metabolic systems (11.1% of patients at encounters and 7.0% of the population).Conclusions and implications: A significant proportion of Australians have not only multimorbidity, but complex multimorbidity. To meet the challenge posed by complex multimorbidity, the single disease focus of our healthcare system needs to be re-evaluated.